Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease

Burbulla, Lena F., Song, Pingping, Mazzulli, Joseph R., Zampese, Enrico, Wong, Yvette C., Jeon, Sohee, Santos, David P., Blanz, Judith +8 more·2017·Science

DOI 10.1126/science.aam9080

Cited by (875)

Items 401–500 of 875

Dysregulation of mitochondrial α-ketoglutarate dehydrogenase leads to elevated lipid peroxidation in CHCHD2-linked Parkinson’s disease models
Ge Gao, Yongyong Shi, Han‐Xiang Deng, Dimitri Krainc · 2025 · Nature Communications
Advances in research on mitochondrial dysfunction in neurodegenerative diseases
Yao Zhang, Xiaowen Li, Yuan Zhang, Xing Li · 2025 · Journal of Neurology
Proteome-Wide Profiling of Cellular Targets Modified by Dopamine Metabolites Using a Bio-Orthogonally Functionalized Catecholamine
Alexander K. Hurben, Luke N. Erber, Natalia Y. Tretyakova, Todd M. Doran · 2021 · ACS Chemical Biology
Antiparkinsonian effects of polyphenols: A narrative review with a focus on the modulation of the gut-brain axis
Wei Zhang, Xiaoyu Dong, Rui Huang · 2023 · Pharmacological Research
Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson’s disease
Makoto Naoi, Wakako Maruyama, Masayo Shamoto‐Nagai, Peter Franz Riederer · 2024 · Journal of Neural Transmission
Stem cells: A path towards improved epilepsy therapies
Zane R. Lybrand, Sonal Goswami, Jenny Hsieh · 2019 · Neuropharmacology
Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synuclein
Landeck, Natalie, Strathearn, Katherine E., Ysselstein, Daniel, Buck, Kerstin, Dutta, Sayan, Banerjee, Siddhartha, Lv, Zhengjian, Hulleman, John D., Hindupur, Jagadish, Lin, Li-Kai et al. · 2020 · Molecular Neurodegeneration
Advances in Fluorescence Techniques for the Detection of Hydroxyl Radicals near DNA and Within Organelles and Membranes
Eleanor Clare Ransdell-Green, Janina Baranowska‐Kortylewicz, Dong Wang · 2025 · Antioxidants
Alpha-Synuclein drives NURR1 and NLRP3 Inflammasome dysregulation in Parkinson's disease: From pathogenesis to potential therapeutic strategies
Ahmed M Abdelaziz · 2025 · International Immunopharmacology
Neuromelanin and selective neuronal vulnerability to Parkinson’s disease
Anastasia Filimontseva, YuHong Fu, Miquel Vila, Glenda Margaret Halliday · 2025 · Trends in Neurosciences
Structural Features and Toxicity of α-Synuclein Oligomers Grown in the Presence of DOPAC
Luana Palazzi, Benedetta Fongaro, Manuela Leri, Laura Acquasaliente, Massimo Stefani, Monica Bucciantini, Patrizia Polverino de Laureto · 2021 · International Journal of Molecular Sciences
The Zinc Ionophore Clioquinol Reduces Parkinson’s Disease Patient-Derived Brain Extracts-Induced Neurodegeneration
Margaux Teil, Évelyne Doudnikoff, Marie-Laure Thiolat, Sylvain Bohic, Erwan Bézard, Benjamin Dehay · 2022 · Molecular Neurobiology
The evolution of organellar calcium mapping technologies
Matthew A. Zajac, Souvik Modi, Yamuna Krishnan · 2022 · Cell Calcium
Natural variation in age-related dopamine neuron degeneration is glutathione dependent and linked to life span
Colin R. Coleman, Judit Pallos, Alicia Arreola-Bustos, Lu Wang, Daniel Raftery, Daniel Promislow, Ian Martin · 2024 · Proceedings of the National Academy of Sciences
Enhancing the Activity of Glucocerebrosidase as a Treatment for Parkinson Disease
Elisa Menozzi, Anthony H.V. Schapira · 2020 · CNS Drugs
Murine Models of Lysosomal Storage Diseases Exhibit Differences in Brain Protein Aggregation and Neuroinflammation
Jennifer Leigh Clarke, Can Kayatekin, Catherine Viel, Lamya S. Shihabuddin, S. Pablo Sardi · 2021 · Biomedicines
Gangliosides as Biomarkers of Human Brain Diseases: Trends in Discovery and Characterization by High-Performance Mass Spectrometry
Mirela Sârbu, Raluca Ică, Alina Diana Zamfir · 2022 · International Journal of Molecular Sciences
In situ fluorescence imaging reveals that mitochondrial H 2 O 2 mediates lysosomal dysfunction in depression
Xin Wang, Qi Ding, Ying Tian, Wei Wu, Feida Che, Ping Li, Wen Zhang, Wei Zhang, Bo Tang · 2022 · Chemical Communications
Identification of ASCL1 as a determinant for human iPSC-derived dopaminergic neurons
Aaron M. Earley, Lena F. Burbulla, Dimitri Krainc, Rajeshwar B. Awatramani · 2021 · Scientific Reports
DJ-1 protects proteins from acylation by catalyzing the hydrolysis of highly reactive cyclic 3-phosphoglyceric anhydride
Aizhan Akhmadi, Adilkhan Yeskendir, Nelly Dey, Arman Mussakhmetov, Zariat Shatkenova, Arman Kulyyassov, Anna Y. Andreeva, Darkhan Utepbergenov · 2024 · Nature Communications
The “Sick-but-not-Dead” Phenomenon Applied to Catecholamine Deficiency in Neurodegenerative Diseases
David S. Goldstein · 2020 · Seminars in Neurology
Current State-of-the-Art and Unresolved Problems in Using Human Induced Pluripotent Stem Cell-Derived Dopamine Neurons for Parkinson’s Disease Drug Development
Stanislav A. Antonov, Ekaterina V. Novosadova · 2021 · International Journal of Molecular Sciences
Basal Ganglia Atrophy as a Marker for Prodromal X‐Linked Dystonia‐Parkinsonism
Henrike Hanßen, Cid Czarina E. Diesta, Marcus Heldmann, Jackson Dy, Jeffrey Tantianpact, Julia Steinhardt, Rosanna Sauza, Hans T. S. Manalo, Andreas Sprenger, Charles Jourdan Reyes et al. · 2023 · Annals of Neurology
Shifting the trajectory of therapeutic development for neurological and psychiatric disorders
Dimitri Krainc, William J. Martin, Bradford H. Casey, Frances E. Jensen, Sarah A. Tishkoff, William Z. Potter, Steven E. Hyman · 2023 · Science Translational Medicine
Targeted reversal of iron deposition by highly active manganese-doped carbon dots in MRI-guided treatment of Parkinson's disease
Huihui Wang, Maolin Zhang, Dongchuan Chu, Xueping Huang, Yu Shi, Yi Yang Zhao, Hang Qu, Dandan Li, Zhuobin Xu, Xiaohong Wang et al. · 2025 · Carbon
Commander complex regulates lysosomal function and is implicated in Parkinson’s disease risk
Georgia Minakaki, Nathaniel Safren, Bernabé I. Bustos, Steven J Lubbe, Niccolò Emanuele Mencacci, Dimitri Krainc · 2025 · Science
Dissecting the non-neuronal cell contribution to Parkinson’s disease pathogenesis using induced pluripotent stem cells
Pons-Espinal, Meritxell, Blasco-Agell, Lucas, Consiglio, Antonella · 2021 · Cellular and Molecular Life Sciences
Mitochondrial Phenotypes in Parkinson’s Diseases—A Focus on Human iPSC-Derived Dopaminergic Neurons
Leonie M. Heger, Rachel M. Wise, J. Tabitha Hees, Angelika Bettina Harbauer, Lena F. Burbulla · 2021 · Cells
Parkin as a Molecular Bridge Linking Alzheimer’s and Parkinson’s Diseases?
Frédéric Checler, Cristine Alvès da Costa · 2022 · Biomolecules
Recent Advances in the Treatment of Genetic Forms of Parkinson’s Disease: Hype or Hope?
Francesco Cavallieri, Rubens Gisbert Cury, Thiago Gonçalves Guimarães, Valentina Fioravanti, Sara Grisanti, Jessica Rossi, Edoardo Monfrini, Marialuisa Zedde, Alessio Di Fonzo, Franco Valzania et al. · 2023 · Cells
Insights into GBA Parkinson's disease pathology and therapy with induced pluripotent stem cell model systems
Pascale Baden, Cong Yu, Michela Deleidi · 2019 · Neurobiology of Disease
Shared Pathological Mechanisms Between Diabetes Mellitus and Neurodegenerative Diseases
Ava Nasrolahi, Javad Mahmoudi, Ali Noori-Zadeh, Karimeh Haghani, Salar Bakhtiyari, Shahram Darabi · 2019 · Current Pharmacology Reports
MicroRNA-93 Blocks Signal Transducers and Activator of Transcription 3 to Reduce Neuronal Damage in Parkinson’s Disease
Xiufeng Wang, Zhijun Liu, Fang Wang · 2021 · Neurochemical Research
A molecular framework for autistic experiences: Mitochondrial allostatic load as a mediator between autism and psychopathology
Caitlyn Mahony, Colleen O’Ryan · 2022 · Frontiers in Psychiatry
Luminol electrochemiluminescence by combining cathodic reduction and anodic oxidation at regenerable cobalt phthalocyanine modified carbon paste electrode for dopamine detection
Zhiyong Dong, Fangxin Du, Tesfaye Hailemariam Barkae, Kaixiang Ji, Fangshuo Liu, Dmytro Viktorovych Snizhko, Yiran Guan, Guobao Xu · 2022 · Electrochimica Acta
Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson’s disease model
Rupsha Mondal, Chayan Banerjee, Sumangal Nandy, Moumita Roy, Joy Chakraborty · 2023 · Cell & Bioscience
Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson’s Disease
Yashumati Ratan, Aishwarya Rajput, Ashutosh Pareek, Aaushi Pareek, Vivek Kumar Jain, Sonia Sonia, Zeba Farooqui, Ranjeet Kaur, Gurjit Singh · 2024 · Biomolecules
Levodopa Impairs the Energy Metabolism of the Basal Ganglia In Vivo
Jannik Prasuhn, Tanja Schiefen, Theresia Güber, Julia Henkel, Jan Christoph Uter, Julia Steinhardt, Britta Wilms, Norbert Brüggemann · 2024 · Annals of Neurology
Altered regulation of serum lysosomal acid hydrolase activities in Parkinson's disease: A potential peripheral biomarker?
Yoshiki Niimi, Shinji Ito, Yasuaki Mizutani, Kenichiro Murate, Sayuri Shima, Akihiro Ueda, Wataru Satake, Nobutaka Hattori, Tatsushi Toda, Tatsuro Mutoh · 2018 · Parkinsonism & Related Disorders
Estimates of Intracellular Dopamine in Parkinson’s Disease: A Systematic Review and Meta-Analysis
Jonathan Sackner‐Bernstein · 2021 · Journal of Parkinson s Disease
Amyloid-mimicking toxic nanofibers generated via self-assembly of dopamine
Kailash Prasad Prajapati, Bibin Gnanadhason Anand, Masihuzzaman Ansari, Mayur Temgire, Ashu Bhan Tiku, Karunakar Kar · 2022 · Nanoscale
MicroRNAs Modulating Neuroinflammation in Parkinson's disease
Mohamed Jamal Saadh, Faris Anad Muhammad, Anamika Singh, Mohammed Ahmed Mustafa, Rafil Adnan Hussein Al Zuhairi, Pallavi Ghildiyal, Ghassan Mudher Hashim, Fahad Alsaikhan, Shayan Khalilollah, Reza Akhavan‐Sigari · 2024 · Inflammation
Innovative Applications and Perspectives of Surface‐Enhanced Raman Spectroscopy Technology in Biomedicine
Lei Xu, Yujiao Xie, Aochi Liu, Liting Xie, Xinyu Miao, Zhiwei Hou, Lingchao Xiang, Tianan Jiang, Aiguo Wu, Jie Lin · 2024 · Small
Are oligodendrocytes bystanders or drivers of Parkinson’s disease pathology?
José Maria Salazar Campos, L. Burbulla, S. Jäkel · 2025 · PLoS Biology
Novel strategies targeting mitochondria-lysosome contact sites for the treatment of neurological diseases
Yinyin Xie, Wenlin Sun, Aoya Han, Xinru Zhou, Shijie Zhang, Chuchu Shen, Yi Xie, Cui Wang, Nanchang Xie · 2025 · Frontiers in Molecular Neuroscience
CCL21-CCR7 blockade prevents neuroinflammation and degeneration in Parkinson’s disease models
Felipe Saceanu Leser, Flavio de Souza Júnyor, Iohanna Bianca Pagnoncelli, Anna Beatriz Temoteo Delgado, Isabelle Medeiros, Ana Clara Campanelli Nóbrega, Brenda da Silva Andrade, Maiara N. Lima, Nicolas Raposo Silva, Laurent Jacob et al. · 2025 · Journal of Neuroinflammation
Motor and non-motor fluctuations in Parkinson’s disease: the knowns and unknowns of current therapeutic approaches
Martin Regensburger, Ilona Csóti, Wolfgang H. Jost, Zacharias Kohl, Stefan Lorenzl, David José Pedrosa, Paul Lingor · 2025 · Journal of Neural Transmission
Adaptations in Mitochondrial Function Induced by Exercise: A Therapeutic Route for Treatment-Resistant Depression
Arnulfo Ramos‐Jiménez, Mariazel Rubio-Valles, Javier A. Ramos-Hernández, Everardo González-Rodríguez, Verónica Moreno-Brito · 2025 · International Journal of Molecular Sciences
In vivo overexpression of synaptogyrin‐3 promotes striatal synaptic dopamine uptake in LRRK2 R1441G mutant mouse model of Parkinson's disease
Philip Wing‐Lok Ho, Lingfei Li, Hui‐Fang Liu, Zoe Yuen-Kiu Choi, Eunice Eun Seo Chang, Shirley Yin‐Yu Pang, Yasine Malki, Chi-Ting Leung, Michelle Hiu-Wai Kung, David Boyer Ramsden et al. · 2023 · Brain and Behavior
Linking Mitochondrial Dysfunction, Neurotransmitter, and Neural Network Abnormalities and Mania: Elucidating Neurobiological Mechanisms of the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder
Zachary Freyberg, Ana C. Andreazza, Colleen A. McClung, Mary Louise Phillips · 2024 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
Longitudinal neuromelanin changes in prodromal and early Parkinson’s disease in humans and rat model
J. Pérot, Anthony Ruze, Rahul Gaurav, Sana Rebbah, Capucine Cadin, Arnaud Le Troter, Lucas Soustelle, Laura Mouton, Romain Valabrègue, Annabelle Parent et al. · 2025 · Brain Communications
Genome-Edited, TH-expressing Neuroblastoma Cells as a Disease Model for Dopamine-Related Disorders: A Proof-of-Concept Study on DJ-1-deficient Parkinsonism
Jannik Prasuhn, Christoph U. Mårtensson, Victor Krajka, Christine Klein, Aleksandar Raković · 2018 · Frontiers in Cellular Neuroscience
Effects of Acute Ethanol Administration on Brain Oxidative Status: The Role of Acetaldehyde
Pablo Baliño, Ricard Romero‐Cano, Juan V. Sanchez‐Andrés, Victoria Valls, Carlos González Aragón, María Muriach · 2019 · Alcoholism Clinical and Experimental Research
Analysis of α-synuclein levels related to LRRK2 kinase activity: from substantia nigra to urine of patients with Parkinson’s disease
Daleum Nam, Ami Kim, Sun Jung Han, Sung-Ik Lee, Sung‐Hye Park, Wongi Seol, Ilhong Son, Dong Hwan Ho · 2021 · Animal Cells and Systems
Patient-Specific iPSCs-Based Models of Neurodegenerative Diseases: Focus on Aberrant Calcium Signaling
Dmitriy A. Grekhnev, Elena V. Kaznacheyeva, Vladimir A. Vigont · 2022 · International Journal of Molecular Sciences
Are we listening to everything the PARK genes are telling us?
Deanna L. Benson, George W. Huntley · 2019 · The Journal of Comparative Neurology
AMPK mediates the neurotoxicity of iron oxide nanoparticles retained in mitochondria or lysosomes
Hui Huang, Mengxue Zhou, Lifo Ruan, Dongqing Wang, Huiru Lu, Jiayu Zhang, Jun Chen, Yi Hu, Zhifang Chai · 2019 · Metallomics
Communications Among Neurocytes in Parkinson's Disease Regulated by Differential Metabolism and Blood‐Brain Barrier Traversing of Chiral Gold Cluster‐MOF Integrated Nanoparticles
Junyang Chen, Gaoxiang Xu, Runpu Shen, Jianzhong Xu, Congcong Lu, Xin Li, Qi Feng, Qing Li · 2025 · Advanced Science
Pathological Mechanisms and Clinical Aspects of GBA1 Mutation-Associated Parkinson’s Disease
Thomas B. Stoker, Kelli Torsney, Roger A. Barker · 2018 · Codon Publications eBooks
Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson’s Disease
Jeffrey J. Kim, Etienne W. Daadi, Thomas T Oh, Elyas S. Daadi, Marcel M. Daadi · 2022 · Genes
Parkin coregulates glutathione metabolism in adult mammalian brain
Daniel N. El Kodsi, Jacqueline M. Tokarew, Rajib Sengupta, Nathalie A. Lengacher, Ajanta Chatterji, Angela Nguyen, Heather Boston, Qiubo Jiang, Carina Palmberg, Chantal A. Pileggi et al. · 2023 · Acta Neuropathologica Communications
Aging and Parkinson’s disease: a complex interplay of vulnerable neurons, the immune system and the blood-brain barrier
Jonas Bendig, Anika K. Frank, Heinz Reichmann · 2024 · Ageing and Neurodegenerative Diseases
A transient post-translational modification of active site cysteine alters binding properties of the parkinsonism protein DJ-1
Arman Mussakhmetov, I.A. Shumilin, Raushan Nugmanova, Ivan G. Shabalin, Timur Baizhumanov, Daulet Toibazar, Bekbolat Khassenov, Wladek Minor, Darkhan Utepbergenov · 2018 · Biochemical and Biophysical Research Communications
Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson’s disease
Elena Coccia, Tim Ahfeldt · 2021 · Stem Cell Research & Therapy
Stress-induced phospho-ubiquitin formation causes parkin degradation
Lyudmila Kovalchuke, Eugene V. Mosharov, Oren A. Levy, Lloyd A. Greene · 2019 · Scientific Reports
The Parkinson’s disease DJ-1 / PARK7 gene controls peripheral neuronal excitability and painful neuropathy
Sang Hoon Lee, Raquel Tonello, Kihwan Lee, Jueun Roh, Arthur Silveira Prudente, Yong Ho Kim, Chul‐Kyu Park, Temugin Berta · 2024 · Brain
TMEM175 does not function as a proton-selective ion channel to prevent lysosomal over-acidification
Erika A. Riederer, Vedrana Mikušević, Tuoxian Tang, Lillian Martin, Joseph A. Mindell, Dejian Ren · 2025 · The Journal of Cell Biology
iPSC‐based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation
Alba Tristán‐Noguero, Irene Fernández‐Carasa, Carles Calatayud, Cristina Bermejo‐Casadesús, Meritxell Pons‐Espinal, Arianna Colini Baldeschi, Leticia Campa, Francesc Artigas, Analı́a A Bortolozzi, Rosario Domingo Jiménez et al. · 2023 · EMBO Molecular Medicine
Targeting the Cysteine Redox Proteome in Parkinson’s Disease: The Role of Glutathione Precursors and Beyond
Marcos Martı́nez · 2023 · Antioxidants
Dopamine‑iron homeostasis interaction rescues mitochondrial fitness in Parkinson's disease
Chiara Buoso, Markus Seifert, Martin Lang, Corey M. Griffith, Begoña Talavera Andújar, Maria Paulina Castelo Rueda, Christine Fischer, Carolina Doerrier, Heribert Talasz, Alessandra Zanon et al. · 2024 · Neurobiology of Disease
Programmed cell death and melatonin: A comprehensive review
Mahdi Rafiyan, Russel Joseph Reiter, Sayyed Mehdi Rasooli Manesh, Reza Asemi, Mehran Sharifi, Sotoudeh Mohammadi, Mohammad Alì Mansournia, Zatollah Asemi · 2024 · Functional & Integrative Genomics
Reactive oxygen species and neurodegenerative diseases: insights into nanozyme therapeutics
Luo Wang, Feixiang Chen, Cuiling Zhang, Yuen Yee Cheng, Wenbo Bu, Yanyan Liu · 2024 · MedMat.
TRH Analog, Taltirelin Improves Motor Function of Hemi-PD Rats Without Inducing Dyskinesia via Sustained Dopamine Stimulating Effect
Cong Zheng, Guiqin Chen, Yang Tan, Weiqi Zeng, Qiwei Peng, Ji Wang, Chi Cheng, Xiaoman Yang, Shuke Nie, Yan Xu et al. · 2018 · Frontiers in Cellular Neuroscience
Hispidin in the Medicinal Fungus Protects Dopaminergic Neurons from JNK Activation-Regulated Mitochondrial-Dependent Apoptosis in an MPP+-Induced In Vitro Model of Parkinson’s Disease
Mei-Chou Lai, Wayne-Young Liu, Shorong‐Shii Liou, I-Min Liu · 2023 · Nutrients
Construction of chemoreactive heterogeneous nanofibers through strategic coassembly of different proteins
M. Ansari, Kailash Prasad Prajapati, Bibin Gnanadhason Anand, P. Chaudhuri, S. Mittal, Karunakar Kar · 2023 · Materials Today Nano
Pluripotent stem cells for neurodegenerative disease modeling: an expert view on their value to drug discovery
Shi-Dong Chen, Hong‐Qi Li, Mei Cui, Qiang Dong, Jin‐Tai Yu · 2020 · Expert Opinion on Drug Discovery
Research models to study lewy body dementia
Suelen Lucio Boschen, Aarushi A. Mukerjee, Ayman H. Faroqi, Benjamin E. Rabichow, John Denis Fryer · 2025 · Molecular Neurodegeneration
DJ-1/PARK7 in Parkinson’s disease: mechanisms of pathogenesis and therapeutic potential
Weicong Bao, Ying Ge, Juan Huang, Yuanyuan Li, Yong Luo, Nanqu Huang · 2025 · Neuroscience
Neuroprotective effects of a novel peptide from Lignosus rhinocerotis against 6‐hydroxydopamine‐induced apoptosis in PC12 cells by inhibiting NF‐κB activation
Chuan Xiong, Zhu Yu, Qiang Luo, Chia‐Wei Phan, Yujie Huo, Ping Li, Qiang Li, Xin Jin, Wenli Huang · 2022 · Food Science & Nutrition
Iron- and Neuromelanin-Weighted Neuroimaging to Study Mitochondrial Dysfunction in Patients with Parkinson’s Disease
Benjamín Pizarro-Galleguillos, Liesa Kunert, Norbert Brüggemann, Jannik Prasuhn · 2022 · International Journal of Molecular Sciences
Dopamine modification of glycolytic enzymes impairs glycolysis: possible implications for Parkinson’s disease
Bing Chen, Qian Zhang, Xiaoru Zhong, Xinwei Zhang, Xin Liu, Hongyang Wang, Fan Yang, Jingjing Zhang, Jingnan Huang, Yin‐Kwan Wong et al. · 2024 · Cell Communication and Signaling
The Contribution of Type 2 Diabetes to Parkinson’s Disease Aetiology
Samo Ribarič · 2024 · International Journal of Molecular Sciences
Determination of Dopamine Using 2-(4-Boronophenyl)quinoline-4-carboxylic Acids as Fluorescent Probes
Hao Wang, Guiqian Fang, Kai Wang, Zhongyu Wu, Qingqiang Yao · 2018 · Analytical Letters
Enhancement of anti-inflammatory effect of cattle bile by fermentation and its inhibition of neuroinflammation on microglia by inhibiting NLRP3 inflammasome
Yuying Pei, Fafeng Cheng, Wěi Li, Qiaoyu Yu, Chongyang Ma, Yan Zou, Tian Xu, Shilin Liu, Shuang Zhang, Qingguo Wang · 2021 · Journal of Bioscience and Bioengineering
Monoterpenoid Epoxidiol Ameliorates the Pathological Phenotypes of the Rotenone-Induced Parkinson’s Disease Model by Alleviating Mitochondrial Dysfunction
Yulia R. Aleksandrova, Kirill Chaprov, Alexandra V. Podturkina, Oleg V. Ardashov, Ekaterina Yu. Yandulova, Konstantin Petrovich Volcho, Nariman Faridovich Salakhutdinov, Маргарита Е. Неганова · 2023 · International Journal of Molecular Sciences
Inhibition of EHMT1/2 rescues synaptic damage and motor impairment in a PD mouse model
Zhixiong Zhang, Rui Wang, Hui Zhou, Dan Wu, Yifan Cao, Chuang Zhang, Hongyang Sun, Chenchen Mu, Zongbing Hao, Haigang Ren et al. · 2024 · Cellular and Molecular Life Sciences
Preserved striatal innervation maintains motor function despite severe loss of nigral dopaminergic neurons
Thomas Paß, Konrad M. Ricke, Pierre Hofmann, Roy Chowdhury, Yu Nie, Patrick Francis Chinnery, Heike Endepols, Bernd Neumaier, Andre Ferrer Carvalho, Lionel Rigoux et al. · 2024 · Brain
Exploring the link between pyrethroids exposure and dopaminergic degeneration through morphometric, immunofluorescence, and in-silico approaches: the therapeutic role of chitosan-encapsulated curcumin nanoparticles
Badriyah Shadid Alotaibi, Amany Abdel-Rahman Mohamed, Yasmina M. Abd‐Elhakim, Ahmed Elsayed Noreldin, Moustafa Elhamouly, Tarek Khamis, Ali H. El‐Far, Manal E. Alosaimi, Naief A. Dahran, Leena S. Alqahtani et al. · 2024 · Frontiers in Pharmacology
Diverse Functions of Parkin in Midbrain Dopaminergic Neurons
Pingping Song, Dimitri Krainc · 2024 · Movement Disorders
Mesenchymal stromal cells deliver H2S-enhanced Nrf2 via extracellular vesicles to mediate mitochondrial homeostasis for repairing hypoxia-ischemia brain damage
Chengcheng Gai, Tingting Li, Yijing Zhao, Yahong Cheng, Yan Y. Song, Qian Luo, Dexiang Liu, Zhen Wang · 2024 · Free Radical Biology and Medicine
Too much for your own good: Excessive dopamine damages neurons and contributes to Parkinson's disease
Anna Masato, Luigi Bubacco, Elisa Greggio · 2021 · Journal of Neurochemistry
Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson’s disease models
Lena F. Burbulla, Jianbin Zheng, Pingping Song, Weilan Jiang, Michaela Johnson, Patrik Brundin, Dimitri Krainc · 2021 · JCI Insight
DJ‐1 depletion prevents immunoaging in T‐cell compartments
Ni Zeng, Christophe Capelle, Alexandre Baron, Takumi Kobayashi, Severine Cire, Vera Tslaf, Cathy Leonard, Djalil Coowar, Haruhiko Koseki, Astrid M Westendorf et al. · 2022 · EMBO Reports
Neuroprotective microRNA-381 Binds to Repressed Early Growth Response 1 (EGR1) and Alleviates Oxidative Stress Injury in Parkinson’s Disease
Shaozhen Guo, Yuting Gao, Yuwei Zhao · 2023 · ACS Chemical Neuroscience
A SERS Composite Hydrogel Device for Point-of-Care Analysis of Neurotransmitter in Whole Blood
Lei Wu, Xuefeng Liu, Shenfei Zong, Zhuyuan Wang, Yiping Cui · 2023 · Biosensors
Pre-aggregation kinetics and intermediates of α-synuclein monitored by the ESIPT probe 7MFE
Jonathan A. Fauerbach, Thomas M. Jovin · 2017 · European Biophysics Journal
Therapeutic Potential of Baicalein in Parkinson’s Disease: Focus on Inhibition of α-Synuclein Oligomerization and Aggregation
Hayate Javed, Shreesh Kumar Ojha · 2019 · IntechOpen eBooks
Mitochondria-targeted aggregation-induced emission active near infrared fluorescent probe for real-time imaging
Yanjing Dong, Zikang Chen, Meirong Hou, Qi Li, Chenggong Yan, Xiaodan Lü, Ruiyuan Liu, Yikai Xu · 2019 · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy
Schisandra chinensis water extract protects ethanol‐induced neurotoxicity in Caenorhabditis elegans
Zhongqin Wu, Ke Li, Xing Tian, Ming‐Xi Zhou, Zongjun Li · 2020 · Journal of Food Biochemistry
Domain-Independent Inhibition of CBP/p300 Attenuates α-Synuclein Aggregation
Irena Hlushchuk, Heikki J Ruskoaho, Andrii Domanskyi, Mikko Airavaara, Mika J. Välimäki · 2021 · ACS Chemical Neuroscience